AI-Designed Vaccine Shatters 2026: Empirical Immunology Dies

In 2026, the first successful human trial of a vaccine entirely designed by computer simulations marks the death of empirical immunology. This AI-driven breakthrough, led by Cambridge and DIOSynVax, compresses vaccine development from years to months, fundamentally altering global pandemic preparedness and signaling a new era of predictive biology.